China SXT Pharmaceuticals (SXTC) Assets Average (2018 - 2025)

China SXT Pharmaceuticals' Assets Average history runs 8 years deep, the most recent figure standing at $24.0 million for Q3 2025.

• In Q3 2025, Assets Average fell 11.28% year-over-year to $24.0 million; the TTM figure through Sep 2025 stood at $24.0 million (down 11.28% YoY), while the FY2025 annual figure was $22.4 million, down 14.98% from the prior year.
• Assets Average was $24.0 million for Q3 2025 at China SXT Pharmaceuticals, down from $26.3 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $29.3 million in Q1 2021 to a low of $18.9 million in Q1 2024.
• Historically, Assets Average has averaged $25.8 million across 5 years, with a median of $26.7 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Assets Average slipped 27.1% in 2024, then surged 39.63% in 2025.
• A 5-year view of Assets Average shows it stood at $28.6 million in 2021, then retreated by 2.6% to $27.9 million in 2022, then dropped by 20.79% to $22.1 million in 2023, then advanced by 22.61% to $27.1 million in 2024, then fell by 11.28% to $24.0 million in 2025.
• The last three Assets Average figures came in at $24.0 million (Q3 2025), $26.3 million (Q1 2025), and $27.1 million (Q3 2024), per Business Quant data.